Both in Pharmaceuticals
Yarrow Bioscience vs Foghorn Therapeutics
Over the past year YARW returned −44.8% and FHTX returned −52.5%; their daily moves had a correlation of 0.11.
YARW −44.8% FHTX −52.5%Growth of $1, one year, split-adjusted
| Metric | YARW | FHTX |
|---|---|---|
| Price | $14.91 | $2.10 |
| Market cap | $125.8M | $124.7M |
| Today | −18.84% | −1.41% |
| 1 month | −20.4% | +6.6% |
| 6 months | — | −55.1% |
| Year to date | — | −61.1% |
| 1 year | — | −50.1% |
| Revenue growth (YoY) | — | +112.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −44.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.4× |
| Net cash | — | $167.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | 98.0% |
| Short % of float | 2.0% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).